A clinico hematological correlation of autoimmune hemolytic anemia and its clinical implication

Parth R. Goswami, Shweta B. Chaudhary


Introduction: Autoimmune hemolytic anemia characterized by production of antibodies that attach to Red cells resulting in their destruction causing anemia. AIHA could be primary or secondary to some other cause. The positive DCT is hallmark for diagnosis of AIHA. Aim of Study: To perform clinical and hematological study of AIHA and from available data to derive necessary conclusion for accurate diagnosis of AIHA. Material and Methods: The prospective study was carried out in blood bank at tertiary care hospital in positive DCT cases from suspected AIHA cases. The detail history was taken, clinical presentation studied and necessary laboratory investigations like peripheral smear examination, Reticulocyte count, Serum bilirubin, Serum LDH etc done and all data tabulated and  conclusion was made for diagnosing AIHA accurately. DCT was performed both manually and using gel card technology. Conclusion: Females and age group between 20 to 30 have more predilections for developing AIHA. Secondary cases are more common and severity of presentation was aggressive in primary cases as compared to secondary. Such type of study helpful in diagnosis AIHA accurately and delay in treatment can be avoided and awareness can be created .

Full Text:



Singh T.Atlas and text of hematology.Second edition.India New delhi:Avichal publication company;2011.

Robert SS,Eugene MB,Leslie ES.Hematology:Basic principles and Practice.3rded.NewYork:Churchill Livingston;2000.pp.661-730.

Agarwal B. Autoimmune hemolytic anemia. Indian J Pediatr. 1998 Sep-Oct;65(5):663-8.

COOMBS RR, MOURANT AE, RACE RR. A new test for the detection of weak and incomplete Rh agglutinins. Br J Exp Pathol. 1945;26:255-66.

Pirofsky B. Clinical aspects of autoimmune hemolytic anemia. Semin Hematol. 1976 Oct;13(4):251-65.

Choudhary VP,Passi GR,Pati HP. Clinico-hematological spectrum of autoimmune hemolytic anemia:An Indian experience.J Assoc Physicians India.1996;44(2):112-4.

Serrano J. [Autoimmune hemolytic anemia. Review of 200 cases studied in a period of 20 years (1970-1989)]. Sangre (Barc). 1992 Aug;37(4):265-74.

Sokol RJ, Booker DJ, Stamps R. The pathology of autoimmune haemolytic anaemia. J Clin Pathol. 1992 Dec;45(12):1047-52.

Issit P.Serological diagnosis and characterization of causative antibody.In :Chaplin H Jr,editor.Methods in hematology-Immune hemolytic anemia.USA:Churchill Livingston;1985.

Merry AH,Thomson EE,Rawlinson VI,Stratton F.Quantitation of IgG on erythrocytes:Correlation of number of IgG molecules per cell with the strength of the direct and indirect antiglobulin tests.Vox Sang.1984;47(6):73-81.

Chaplin H, Avioli LV. Grand rounds: autoimmune hemolytic anemia. Arch Intern Med. 1977 Mar;137(3):346-51.

Vangelen-Taylor V,editor.Technical Manual of American Association of Blood Banks.12th ed.Maryland:Bathesda;1996.The positive DAT and Immune mediated red cell destruction;pp.379-410.

Jaiprakash M, Gupta PK, Kumar H. Role of gel based technique for Coomb's test. Indian J Pathol Microbiol. 2006 Jul;49(3):370-2.

Garratty G, Petz LD. Drug-induced immune hemolytic anemia. Am J Med. 1975 Mar;58(3):398-407.

Saran RK.Transfusion medicine technical manual.Second ed.India:Directorate general of health services,government of india;2003.

S, Bingham M, Boehni P. Autoimmune hemolytic disease. Antibody dissociation and activity. Arch Intern Med. 1961 Sep;108:338-52.

Arndt PA, Garratty G. Cross-reactivity of cefotetan and ceftriaxone antibodies, associated with hemolytic anemia, with other: cephalosporins and penicillin. Am J Clin Pathol. 2002 Aug;118(2):256-62.


  • There are currently no refbacks.